Evidence map›Paper›PMID 26438297›Full record

ArticleG3 (Bethesda, Md.)2015

A Nonsense Variant in COL6A1 in Landseer Dogs with Muscular Dystrophy.

Frank Steffen, Thomas Bilzer, Jan Brands, Lorenzo Golini, Vidhya Jagannathan, Michaela Wiedmer, Michaela Drögemüller, Cord Drögemüller, Tosso Leeb

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Congenital muscular dystrophy in a dog with a LAMA2 gene deletion.Journal of veterinary internal medicine · 2022
    Article
  4. Genes · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Frank SteffenNeurology Service, Department of Small Animals, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.
Thomas BilzerInstitute of Neuropathology, University Hospital Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Jan BrandsInstitute of Neuropathology, University Hospital Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Lorenzo GoliniNeurology Service, Department of Small Animals, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland.
Vidhya JagannathanInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.
Michaela WiedmerInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.
Michaela DrögemüllerInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.
Cord DrögemüllerInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland.
Tosso LeebInstitute of Genetics, Vetsuisse Faculty, University of Bern, 3001 Bern, Switzerland Tosso.Leeb@vetsuisse.unibe.ch.ORCID http://orcid.org/0000-0003-0553-4880
University of Bern · CHUniversity of Zurich · CHDüsseldorf University Hospital · DEHeinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel canine muscular dystrophy in Landseer dogs was observed. We had access to five affected dogs from two litters. The clinical signs started at a few weeks of age, and the severe progressive muscle weakness led to euthanasia between 5 and 15 months of age. The pedigrees of the affected dogs suggested a monogenic autosomal-recessive inheritance of the trait. Linkage and homozygosity mapping indicated two potential genome segments for the causative variant on chromosomes 10 and 31 harboring a total of 4.8 Mb of DNA or 0.2% of the canine genome. Using the Illumina sequencing technology, we obtained a whole-genome sequence from one affected Landseer. Variants were called with respect to the dog reference genome and compared with the genetic variants of 170 control dogs from other breeds. The affected Landseer dog was homozygous for a single, private nonsynonymous variant in the critical intervals, a nonsense variant in the COL6A1 gene (Chr31:39,303,964G>T; COL6A1:c.289G>T; p.E97*). Genotypes at this variant showed perfect concordance with the muscular dystrophy phenotype in all five cases and more than 1000 control dogs. Variants in the human COL6A1 gene cause Bethlem myopathy or Ullrich congenital muscular dystrophy. We therefore conclude that the identified canine COL6A1 variant is most likely causative for the observed muscular dystrophy in Landseer dogs. On the basis of the nature of the genetic variant in Landseer dogs and their severe clinical phenotype these dogs represent a model for human Ullrich congenital muscular dystrophy.

Indexed as

Codon, NonsenseAnimalsChromosome MappingCollagen Type VIDisease Models, AnimalDNA Mutational AnalysisDogsFemaleGenetic Association StudiesGenetic LinkageGenomeHigh-Throughput Nucleotide SequencingHomozygoteMaleMuscle, SkeletalMuscular DystrophiesCodon, NonsenseCollagen Type VIanimal modeldogMendelian traitsveterinary geneticswhole-genome sequencing

Identifiers

PMID26438297
PMCPMC4683634
OpenAlexW1651053558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.